About DCAT Week 2026
ICE Pharma was excited to return to DCAT Week 2026 that took place in New York City from March 23rd – 26th, 2026.
DCAT Week is the premier annual event for the global bio/pharmaceutical business ecosystem, hosted by the Drug, Chemical & Associated Technologies Association. This influential gathering brings together industry leaders, innovators, and decision-makers for high-level strategic meetings, networking, and collaboration across the entire pharmaceutical supply chain.
We look enjoed connecting with industry professionals, current partners, and prospective collaborators to discuss our comprehensive product portfolio and service capabilities.
Meet Our Team
Our experienced team was available throughout DCAT Week 2026 to discuss your pharmaceutical development and manufacturing needs. Whether you were interested in our APIs, contract manufacturing services, or other pharmaceutical solutions, our specialists were ready to explore how we can support your projects.
- Lotte New York Palace, suite n. 4615
Experts Attended
- Agostino Barazza. Chief Executive Officer
- Roger Viney – Chief Commercial Officer, email: r.viney@icepharma.com
- Viola Gualco – Head of Commercial – UDCA, email: v.gualco@icepharma.com
- Zhong Wang – Head of Specialty Products, email: Zhong.Wang@nzp.co.nz
- Irene Meoni – Sales Area Manager, email: i.meoni@icepharma.com
- Concetto Andrea Rizza – Marketing & Communication Manager, email: c.rizza@icepharma.com
Who We Are
ICE Pharma is a multinational company providing products and services to the pharmaceutical and healthcare markets.
Founded more than 70 years ago, we operate a network of manufacturing facilities and subsidiaries across North and South America, Europe, Asia, and Oceania. We serve customers in over 50 countries, commercializing our products and services in all major global markets.
As a key supplier to the pharmaceutical industry, we provide an extensive range of active pharmaceutical ingredients (APIs) including Ursodeoxycholic acid (UDCA) and Inosine Pranobex. Our portfolio also includes excipients, cell culture media for diagnostics, GMP intermediates, and research chemicals. Through our services business, we offer contract manufacturing for both solid and liquid finished dosage forms.
We also manufacture and commercialize branded products across the pharmaceutical, nutraceutical, and cosmetics markets.